UroGen Pharma Ltd News

UroGen Pharma Ltd | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Pontifax Management III G.P. (2011) Ltd.(4.4%),Pontifax Management Fund III L.P.(4.4%), etc.

Nov 18, 2024 06:19 ET

UroGen Pharma Ltd | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Point72 Asset Management, L.P.(3.6%),Point72 Capital Advisors, Inc.(3.6%), etc.

Nov 14, 2024 19:52 ET

UroGen Pharma Ltd | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-RA Capital Management, L.P.(7.1%),Peter Kolchinsky(7.1%), etc.

Nov 14, 2024 17:51 ET

UroGen Pharma Ltd | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Great Point Partners, LLC(1.80%),Dr. Jeffrey R. Jay, M.D.(1.80%), etc.

Nov 14, 2024 16:53 ET

UroGen Pharma Ltd | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Menora Mivtachim Holdings Ltd.(5.47%),Menora Mivtachim Pensions and Gemel Ltd.(4.79%)

Nov 14, 2024 12:09 ET

UroGen Pharma Ltd | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-RTW Investments, LP(9.99%),Roderick Wong, M.D.(9.99%)

Nov 14, 2024 06:46 ET

UroGen Pharma Ltd | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Cowen Financial Products LLC(4.3%),Cowen and Company, LLC(0%)

Nov 13, 2024 08:42 ET

UroGen Pharma Ltd | SC 13G: Statement of acquisition of beneficial ownership by individuals-Adage Capital Management, L.P.(8.87%),Robert Atchinson(8.87%), etc.

Nov 12, 2024 09:40 ET

UroGen Pharma Ltd | SC 13G: Statement of acquisition of beneficial ownership by individuals-BlackRock, Inc.(5.9%)

Nov 8, 2024 14:30 ET

UroGen Pharma Ltd | SC 13G: Statement of acquisition of beneficial ownership by individuals-Morgan Stanley(5.2%)

Nov 6, 2024 13:52 ET

UroGen Pharma Ltd | 10-Q: Q3 2024 Earnings Report

Nov 6, 2024 08:07 ET

UroGen Pharma Ltd | 8-K: UroGen Pharma Reports 2024 Third Quarter Financial Results and Business Highlights, Including the Potential Launch of UGN-102 in 2025

Nov 6, 2024 08:07 ET

UroGen Pharma Ltd | SC 13G: Statement of acquisition of beneficial ownership by individuals-BlackRock, Inc.(5.9%)

Oct 24, 2024 14:46 ET

UroGen Pharma Ltd | 4: Statement of changes in beneficial ownership of securities-Officer Degnan Chris

Oct 9, 2024 16:27 ET

UroGen Pharma Ltd | 3: Initial statement of beneficial ownership of securities-Officer Degnan Chris

Oct 9, 2024 16:22 ET

UroGen Pharma Ltd | 8-K: Current report

Oct 9, 2024 08:21 ET

UroGen Pharma Ltd | 8-K: Current report

Sep 24, 2024 16:17 ET

UroGen Pharma Ltd | 8-K: Current report

Sep 13, 2024 16:18 ET

UroGen Pharma Ltd | 4: Statement of changes in beneficial ownership of securities-Officer Schoenberg Mark

Sep 12, 2024 13:59 ET

UroGen Pharma Ltd | 4: Statement of changes in beneficial ownership of securities-Officer Smith Jason Drew

Sep 12, 2024 13:54 ET